Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06821763Phase 3
Key facts
Phase 3, randomised, single-blind trial in apical periodontitis (AP) comparing Calcium Hydroxide with Triple Antibiotic Paste (2 arms). Primary endpoint: Post Operative Pain Severity at 96 hours. Planned start May 2025; status: not yet recruiting.
Calcium Hydroxide
Patients receiving calcium hydroxide as intra canal medicament
Triple Antibiotic Paste
Patients receiving triple antibiotic paste (TAP) as intra canal medicament
Post Operative Pain Severity
Beyond the preview
Full results, competitive context and analysis are in the Gosset platform.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06821763.